Authors: Bar-Shalom, R Mor, M Yefremov, N Goldsmith, SJ

Citation: R. Bar-shalom et al., The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment, SEM NUC MED, 31(3), 2001, pp. 177-190

Authors: Front, D Bar-Shalom, R Mor, M Haim, N Epelbaum, R Frenkel, A Gaitini, D Kolodny, GM Israel, O

Citation: D. Front et al., Aggressive non-Hodgkin lymphoma: Early prediction of outcome with Ga-67 scintigraphy, RADIOLOGY, 214(1), 2000, pp. 253-257

Authors: Bar-Shalom, R

Citation: R. Bar-shalom, Muscle uptake of 18-fluorine fluorodeoxyglucose, SEM NUC MED, 30(4), 2000, pp. 306-309

Authors: Bar-Shalom, R Valdivia, AY Blaufox, MD

Citation: R. Bar-shalom et al., PET imaging in oncology, SEM NUC MED, 30(3), 2000, pp. 150-185

Authors: Front, D Bar-Shalom, R Mor, M Haim, N Epelbaum, R Frenkel, A Gaitini, D Kolodny, GM Israel, O

Citation: D. Front et al., Hodgkin disease: Prediction of outcome with Ga-67 scintigraphy after one cycle of chemotherapy, RADIOLOGY, 210(2), 1999, pp. 487-491